Quarterly report pursuant to Section 13 or 15(d)

12. Stock-based Compensation

v3.10.0.1
12. Stock-based Compensation
9 Months Ended
Jun. 30, 2018
Share-based Compensation [Abstract]  
Stock-based Compensation

Note 12:        Stock-Based Compensation

 

From time to time, the Company grants stock options and restricted stock awards to directors, officers and employees. These awards are valued at the grant date by determining the fair value of the instruments, net of estimated forfeitures. The value of each award is amortized on a straight-line basis over the requisite service period.

 

Stock Options

 

The following table summarizes stock option activity for the nine months ended June 30, 2018:

 

 

Number of

shares

 

Weighted

Average

Exercise

Price

 

Weighted

Average

Remaining Contractual Life

  Intrinsic Value
  Outstanding at September 30, 2017     211,668      $ 13.19       3.47     $ 454,417  
  Granted     20,000       32.24       10.00          
  Exercised     -                          
  Forfeited     -                          
  Outstanding at June 30, 2018     231,668     $ 14.84       3.29     $ 471,458  
  Exercisable at June 30, 2018     187,167     $ 11.75       2.33     $ 471,458  

 

 

The Company recognized compensation expense of $49,817 and $67,491 during the three months ended June 30, 2018 and 2017, respectively. The Company recognized compensation expense of $447,970 and $137,011 during the nine months ended June 30, 2018 and 2017, respectively, related to stock option and warrant extension awards granted to certain employees and officers based on the grant date fair value of the awards, net of estimated forfeitures.

  

At June 30, 2018, the Company has $335,992 of unrecognized compensation expense (net of estimated forfeitures) associated with stock option awards which the company expects to recognize as compensation expense through October of 2022.

 

The exercise price for stock options outstanding and exercisable outstanding at June 30, 2018 is as follows:

 

Outstanding     Exercisable  
Number of     Exercise     Number of     Exercise  
Options     Price     Options     Price  
  31,250     $ 5.00       31,250     $ 5.00  
  25,000       7.50       25,000       7.50  
  31,250       10.00       31,250       10.00  
  4,167       10.86       4,167       10.86  
  4,167       10.86                  
  4,167       10.86                  
  4,167       10.86                  
  6,250       12.50       6,250       12.50  
  6,250       15.00       6,250       15.00  
  75,000       15.18       75,000       15.18  
  8,000       23.41       8,000       15.18  
  8,000       27.60                  
  8,000       31.74                  
  8,000       36.50                  
  8,000       41.98                  
  231,668               187,167          

 

The following table summarizes information about the Company’s non-vested shares outstanding as of June 30, 2018:

 

Non-vested Shares  

Number of

Shares

 

Weighted

Average

Grant-Date

Fair Value

  Non-vested at September 30, 2017       36,668     $ 17.70  
  Granted       20,000     $ 10.14  
  Vested       (12,167 )   $ 13.32  
  Non-vested at June 30, 2018       44,501     $ 13.54  

 

 

 

Options were granted during fiscal 2017 and 2016, where the exercise price was less than the common stock price at the date of grant or where the exercise price was greater than the common stock price at the date of grant. There have been no options granted in fiscal 2018 to date. The assumptions used in calculating the fair value of stock options granted use the Black-Scholes option pricing model for options granted were as follows:

 

Risk-free interest rate   1.25%
Expected life of the options   5.0 to 10.0 years
Expected volatility   107%
Expected dividend yield   0%